![]() |
市場調查報告書
商品編碼
1856998
全球腸道健康飲品及滋補品市場:預測至2032年-依產品類型、劑型、主要成分、通路、特性、應用及地區進行分析Gut Health Shots and Tonics Market Forecasts to 2032 - Global Analysis By Product Type, Form, Base Ingredient, Distribution Channel, Nature, Application and By Geography |
||||||
據 Stratistics MRC 稱,全球腸道健康飲品和滋補品市場預計到 2025 年將達到 12.1 億美元,到 2032 年將達到 20.6 億美元,預測期內複合年成長率為 7.9%。
腸道健康營養液是濃縮液體補充劑,旨在透過增強腸道菌叢平衡、促進營養吸收和改善胃腸道功能來支持消化器官系統健康。這些配方通常含有益生菌、益生元、酵素、草藥和發酵成分,旨在減少腹脹、改善排便規律並增強腸道屏障的完整性。這些產品設計便於快速服用,提供了一種針對性的消化器官系統護理方法,通常作為日常健康養生或功能性營養策略的一部分。其功效取決於成分的品質和個人健康需求。
消費者越來越傾向於尋找天然解決方案。
富含益生菌、益生元和植物萃取物的腸道健康飲品和滋補品正日益受到歡迎,成為合成營養補充劑的便捷替代品。人們對腸道菌叢健康的日益關注,促使消費者尋求能夠支持消化、免疫和整體健康的天然機能飲料。潔淨標示趨勢以及消費者對植物性、低糖配方的偏好進一步推動了這一轉變。隨著消費者越來越重視預防性健康,這些產品正成為日常健康生活方式中不可或缺的一部分,從而推動市場穩定成長。
缺乏標準化的臨床證據
儘管腸道健康飲品廣受歡迎,但許多配方缺乏標準化的臨床證據來證實其健康功效。這種科學檢驗的缺失會阻礙消費者信任,並限制行銷的彈性。此外,機能飲料的法律規範因地區而異,為全球品牌帶來合規挑戰。益生菌功效、使用方法和標籤缺乏統一指南,進一步加劇了產品開發和國際擴張的困難。
與微生物組檢測和人工智慧主導的健康計劃相結合
腸道健康產品與微生物組檢測和數位化健康平台的融合帶來了變革性的機會。各大品牌正探索與生技公司合作,基於個人的微生物組特徵提供個人化的腸道健康解決方案。人工智慧驅動的應用程式和訂閱模式正在提升消費者的參與度和忠誠度,並實現量身定做的產品推薦。這一趨勢與精準營養的廣泛發展趨勢不謀而合,精準營養的核心在於利用數據主導的洞察來指導營養選擇和補充劑的使用。
未經證實的健康聲明
腸道健康領域的快速擴張導致大量產品湧現,這些產品往往做出誇大其詞、缺乏依據的宣傳。這不僅可能招致監管機構的批評,還會損害消費者對正規產品的信任。社群媒體和網紅平台上的假訊息扭曲了消費者的認知,使得以實證為基礎的品牌難以脫穎而出。此外,醫療專業人員的質疑態度也會限制臨床推薦並將其納入正式的健康通訊協定。
新冠疫情初期擾亂了生產和分銷網路,影響了產品供應。然而,疫情也提升了消費者對免疫力和消化器官系統健康的關注度,加速了機能飲料的需求。隨著人們對電商和居家健康生活方式的依賴日益加深,腸道健康飲品和滋補品成為一種便捷的免疫力增強選擇。疫情也推動了常溫保存配方和直銷模式的創新,再形成了市場競爭格局。
預計在預測期內,益生元滋補品細分市場將佔據最大佔有率。
由於益生元滋補品具有廣泛的吸引力,且能滿足各種飲食偏好,預計在預測期內,益生元滋補品將佔據最大的市場佔有率。這些配方無需冷藏即可支持腸道有益菌叢的生長,因此非常適合主流零售和線上通路銷售。其多樣化的口味和功能定位,涵蓋消化器官系統支持、能量補充和皮膚健康等領域,正在幫助消費群。隨著人們對益生元的認知不斷提高,預計該細分市場將繼續保持其領先地位。
預計在預測期內,康普茶細分市場將以最高的複合年成長率成長。
由於發酵和益生菌的雙重益處,預計在預測期內,康普茶類產品將呈現最高的成長率。這些產品吸引了注重健康的消費者,他們追求天然排毒、改善消化和抗氧化功效。口味創新、低糖配方和混合配方(例如康普茶+適應原)正在推動其普及。此外,主流零售商和健康咖啡館的供應量增加也促進了這一細分市場的成長。
預計北美將在預測期內佔據最大的市場佔有率,這主要得益於其成熟的機能飲料產業、較高的消費者意識和強大的零售基礎設施。該地區擁有眾多先鋒品牌,並率先接受了腸道健康理念。對研發、網紅行銷和潔淨標示創新的策略性投資進一步鞏固了該地區的領先地位。此外,人們對整體健康和預防性醫療保健日益成長的興趣也持續推動著該品類的成長。
預計亞太地區在預測期內將實現最高的複合年成長率,這主要得益於健康意識的提高、都市化的加快以及可支配收入的增加。中國、印度和日本等國家對消化器官系統健康食品的需求激增,這得益於人們對發酵食品的傳統認知。政府推行的腸道健康教育措施以及現代零售通路的擴張正在加速市場滲透。本土新興企業和全球參與企業都在尋求透過提供符合當地文化的產品來把握這一充滿活力的市場機會。
According to Stratistics MRC, the Global Gut Health Shots and Tonics Market is accounted for $1.21 billion in 2025 and is expected to reach $2.06 billion by 2032 growing at a CAGR of 7.9% during the forecast period. Gut health shots and tonics are concentrated liquid supplements formulated to support digestive wellness by enhancing microbiome balance, nutrient absorption, and gastrointestinal function. Typically infused with probiotics, prebiotics, enzymes, herbs, or fermented ingredients, these formulations aim to reduce bloating, improve regularity, and strengthen gut barrier integrity. Designed for quick consumption, they offer a targeted approach to digestive care, often used as part of daily wellness routines or functional nutrition strategies. Their efficacy depends on ingredient quality and individual health needs.
Consumers increasingly seek natural solutions
Gut health shots and tonics, often infused with probiotics, prebiotics, and botanical extracts, are gaining traction as convenient alternatives to synthetic supplements. The growing awareness of gut microbiome health is prompting consumers to seek natural, functional beverages that support digestion, immunity, and overall wellness. This shift is further supported by clean-label trends and a preference for plant-based, low-sugar formulations. As consumers prioritize preventive health, these products are becoming staples in daily wellness routines, driving consistent market growth.
Lack of standardized clinical evidence
Despite the popularity of gut health beverages, many formulations lack standardized clinical evidence to substantiate their health claims. This gap in scientific validation can hinder consumer trust and restrict marketing flexibility. Moreover, regulatory frameworks for functional beverages vary across regions, creating compliance challenges for global brands. The absence of harmonized guidelines for probiotic efficacy, dosage, and labeling further complicates product development and international expansion.
Integration with microbiome testing and AI-driven wellness plans
The convergence of gut health products with microbiome testing and digital wellness platforms presents a transformative opportunity. Brands are exploring partnerships with biotech firms to offer personalized gut health solutions based on individual microbiome profiles. AI-powered apps and subscription models are enabling tailored product recommendations, enhancing consumer engagement and loyalty. This trend aligns with the broader shift toward precision nutrition, where data-driven insights inform dietary choices and supplement use.
Unsubstantiated health claims
The rapid expansion of the gut health category has led to a surge in products making bold, often unsubstantiated claims. This not only risks regulatory backlash but also undermines consumer confidence in legitimate offerings. Misinformation on social media and influencer platforms can distort public perception, making it harder for evidence-based brands to differentiate themselves. Additionally, skepticism from healthcare professionals may limit clinical endorsement and integration into formal wellness protocols.
The COVID-19 pandemic initially disrupted manufacturing and distribution networks, affecting product availability. However, it also heightened consumer focus on immunity and digestive health, accelerating demand for functional beverages. With increased reliance on e-commerce and home-based wellness, gut health shots and tonics gained visibility as convenient, immune-supportive options. The pandemic also catalyzed innovation in shelf-stable formulations and direct-to-consumer delivery models, reshaping the competitive landscape.
The prebiotic tonics segment is expected to be the largest during the forecast period
The prebiotic tonics segment is expected to account for the largest market share during the forecast period due to their broad appeal and compatibility with various dietary preferences. These formulations support beneficial gut bacteria without requiring refrigeration, making them ideal for mainstream retail and online distribution. Their versatility in flavoring and functional positioning ranging from digestive support to energy and skin health has expanded their consumer base. As awareness of prebiotics grows, this segment is expected to maintain its leadership.
The kombucha-based segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the kombucha-based segment is predicted to witness the highest growth rate driven by their dual benefits of fermentation and probiotic content. These products appeal to health-conscious consumers seeking natural detoxification, improved digestion, and antioxidant support. Innovations in flavor profiles, sugar reduction, and hybrid formulations (e.g., kombucha + adaptogens) are fueling adoption. The segment is also benefiting from increased availability in mainstream retail and wellness-focused cafes.
During the forecast period, the North America region is expected to hold the largest market share due to its mature functional beverage industry, high consumer awareness, and strong retail infrastructure. The region is home to several pioneering brands and has witnessed early adoption of gut health trends. Strategic investments in R&D, influencer marketing, and clean-label innovation have further solidified its dominance. Additionally, rising interest in holistic wellness and preventive care continues to drive category growth.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by increasing health consciousness, urbanization, and disposable income. Countries like China, India, and Japan are witnessing a surge in demand for digestive health products, supported by traditional knowledge of fermented foods. Government initiatives promoting gut health education and the expansion of modern retail channels are accelerating market penetration. Local startups and global entrants alike are tapping into this dynamic landscape with culturally tailored offerings.
Key players in the market
Some of the key players in Gut Health Shots and Tonics Market include OLIPOP, Poppi, Health-Ade, Suja Life, Remedy Drinks, Culture Pop Soda, GT's Living Foods, Bio-K+ International, GoodBelly, Tropicana Brands Group, Humm Kombucha, Kevita, Symprove, Seed Health, Your Super, MOJU, and The Gut Stuff.
In September 2025, Seed Health New category includes multivitamin, energy, and sleep formulations targeting human and microbial pathways expands Seed's portfolio beyond probiotics into holistic microbiome support.
In September 2025, The Gut Stuff Danone's acquisition of Akkermansia Company signals broader gut health investment. The Gut Stuff remains active in education and community outreach.
In April 2025, Tropicana Brands Group launched "Fresh & Light" juice range, blended fruit juices with reduced sugar and calories to meet health-conscious demand. Part of broader innovation strategy post-PepsiCo divestment.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.